Redenti E, Zanol M, Ventura P, Fronza G, Comotti A, Taddei P, Bertoluzza A
Chemical and Biopharmaceutical Department, Chiesi Farmaceutici S.p.A., Parma, Italy.
Biospectroscopy. 1999;5(4):243-51. doi: 10.1002/(SICI)1520-6343(1999)5:4<243::AID-BSPY5>3.0.CO;2-C.
The results of a Raman and solid state 13C-NMR spectroscopic investigation aimed at studying the conformation of piroxicam (P) and its interaction with beta-cyclodextrin (betaCD) in 1 : 1 amorphous PbetaCD inclusion compound are reported. The 1700-1200 cm(-1) FT-Raman and the 13C CP/MAS NMR spectra of 1 : 1 PbetaCD inclusion compound are discussed and assigned in comparison with those of the three main modifications of piroxicam (alpha, beta, and monohydrate). The FT-Raman and 13C-NMR results show that in 1 : 1 PbetaCD inclusion compound piroxicam mainly assumes the zwitterionic structure typical of monohydrate, even if the presence of a different structure, that is, beta form, is not excluded. Piroxicam monohydrate, differently from alpha and beta forms, is characterized by a zwitterionic structure with an internal proton transfer and an increased charge delocalization, as shown by our spectroscopic results. The charge delocalization characteristic of this zwitterionic structure gives rise to the interaction with betaCD via electrostatic and hydrogen bonds. The possibility of a host-guest interaction between piroxicam and betaCD is not excluded; the guest molecule can be accommodated in betaCD cavity by interaction via hydrophobic bonds.
报道了一项拉曼光谱和固态(^{13}C -)核磁共振光谱研究的结果,该研究旨在研究吡罗昔康(P)的构象及其在(1:1)非晶态(PβCD)包合物中与β - 环糊精(βCD)的相互作用。讨论并归属了(1:1) (PβCD)包合物的(1700 - 1200 cm^{-1})傅里叶变换拉曼光谱和(^{13}C)交叉极化/魔角旋转核磁共振光谱,并与吡罗昔康的三种主要变体(α、β和一水合物)的光谱进行了比较。傅里叶变换拉曼光谱和(^{13}C -)核磁共振结果表明,在(1:1) (PβCD)包合物中,吡罗昔康主要呈现一水合物典型的两性离子结构,即使不排除存在不同结构,即β型。如我们的光谱结果所示,与α和β型不同,吡罗昔康一水合物的特征是具有内部质子转移和电荷离域增加的两性离子结构。这种两性离子结构的电荷离域特性通过静电和氢键与βCD产生相互作用。不排除吡罗昔康与βCD之间存在主客体相互作用的可能性;客体分子可通过疏水键相互作用容纳在βCD腔内。